Author

Zhe Xu

Westlake UniversityORCID 0000-0002-3223-3103Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Zhe Xu1 paper · Guangzhou Laboratory

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Guoshi ChaiiD· 1 shared Jiatong Chen· 1 shared Leping Zhang· 1 shared Ning LiuiD· 1 shared Qian Zhang· 1 shared Qunyu LviD· 1 shared Ruolan Tang· 1 shared Shang CaiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Guoshi ChaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MtDNA heteroplasmy controls tumor immune reprogramming through mitochondrial translation

Ning Liu, Guoshi Chai, Qunyu Lv, Xiaoling Deng, Jiatong Chen, Qian Zhang, Leping Zhang, Xu Liu, Ruolan Tang, Zhe Xu, Shang Cai

The paper shows that mtDNA heteroplasmy regulates tumor progression by modulating mitochondrial translation and immune microenvironment remodeling through the LARS2-S100A8/A9 axis.

bioRxiv · Feb 3, 2026 · PreprintCancer Biology